Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07156227 Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation … |
Biospecimen Collection | Cancer | Phase 1 | RECRUITING | En attente / non publié | City of Hope Medical Center | United States · City of Hope at Irvine Lennar, Irvine… | 2027-02-13 → 2029-05-31 | Ouvrir |
| NCT06727565 VELOCITY-HNSCC — Study of Novel Treatment Combination Therapies in Part… |
Domvanalimab | Cancer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Gilead Sciences | United States, Australia, China, France, Italy, Malay… | 2025-02-18 → 2027-03 | Ouvrir |
| NCT04246177 Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (M… |
Lenvatinib | Cancer | Phase 3 | TERMINATED | En attente / non publié | Zhejiang University | United States, Australia, Brazil, Chile, China, Colom… | 2020-05-22 → 2026-03-26 | Ouvrir |
| NCT06203600 Adding Nivolumab to Usual Treatment for People With Advanced Stomach or… |
Biospecimen Collection | Cancer | Phase 2/3 | RECRUITING | En attente / non publié | City of Hope Medical Center | United States · Abbott-Northwestern Hospital, Minneap… | 2024-06-24 → 2027-10-31 | Ouvrir |
| NCT06084936 GLOBRYTE — A Study to Evaluate Glofitamab as a Single Agent vs. Investi… |
Obinutuzumab | Cancer | Phase 3 | RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Australia, Brazil, Canada, China, Fran… | 2023-10-22 → 2028-03-31 | Ouvrir |
| NCT06337318 Comparing Rituximab and Mosunetuzumab Drug Treatments for People With L… |
Biospecimen Collection | Cancer | Phase 3 | RECRUITING | En attente / non publié | City of Hope Medical Center | United States · Abbott-Northwestern Hospital, Minneap… | 2024-10-23 → 2032-03-31 | Ouvrir |
| NCT06064097 A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Trea… |
Biopsy Procedure | Cancer | Phase 2 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States, Australia, Canada, New Zealand, Puerto… | 2024-06-25 → 2027-03-31 | Ouvrir |
| NCT06136624 OMAHA-003 — Study of Opevesostat (MK-5684) Versus Alternative NHA in mC… |
Opevesostat | Cancer | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Austria, Brazil,… | 2023-12-31 → 2030-02-15 | Ouvrir |
| NCT07491497 A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC |
TRI-611 | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | TRIANA Biomedicines, Inc. | United States, Australia · Dana Farber Cancer Center,… | 2026-03-11 → 2034-01-30 | Ouvrir |
| NCT06790693 INAVO123 — A Study Evaluating the Efficacy and Safety of Inavolisib Plu… |
Inavolisib | Cancer | Phase 3 | RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Australia, Brazil, Canada, … | 2025-04-09 → 2032-02-01 | Ouvrir |
| NCT07623031 Dual-Language B-MORE for Hypertension |
Dual-Language B-MORE for Hyperten… | Hypertension | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Florida State University | United States · Shepherd's Hope Downtown Clinic, Orla… | 2026-06-05 → 2026-12 | Ouvrir |
| NCT04838678 Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN) |
Neuropeptide Y | Hypertension | Phase 1 | RECRUITING | En attente / non publié | University of Texas Southwestern … | United States · University of Texas Southwestern Medi… | 2021-07-18 → 2026-12-31 | Ouvrir |
| NCT06205628 Safety, Tolerability, PK and PD of ADX-850 in Participants With Hyperte… |
ADX-850 | Hypertension | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | ADARx Pharmaceuticals, Inc. | Australia · Clinitrials Pty Ltd, Perth, Australia | C… | 2024-03-21 → 2026-12-31 | Ouvrir |
| NCT07801599 CHAIN3 — Huayu Jiedu Formula (FTFY-919) Granules Versus Traditional Dec… |
Huayu Jiedu Formula (FTFY-919) Gr… | Hypertension | Phase 3 | NOT_YET_RECRUITING | En attente / non publié | Guangzhou University of Tradition… | Non communiqué | 2026-09 → 2028-01 | Ouvrir |
| NCT06778239 Childhood-Onset Essential Hypertension Natural History Study |
Childhood-Onset Essential Hyperte… | Hypertension | À vérifier | RECRUITING | En attente / non publié | National Human Genome Research In… | United States · National Institutes of Health Clinica… | 2025-05-30 → 2034-12-09 | Ouvrir |
| NCT07361276 CLEAR-HTN — Observational Study That Will Evaluate Treatment Patterns i… |
CLEAR-HTN — Observational Study T… | Hypertension | À vérifier | RECRUITING | En attente / non publié | AstraZeneca | Brazil · Research Site, Florianópolis, Brazil | 2026-03-31 → 2026-09-30 | Ouvrir |
| NCT07796633 Findings Of The Video Head Impulse Test In Patients With Vestibular Mig… |
Findings Of The Video Head Impuls… | Migraine | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Sohag University | Non communiqué | 2026-08 → 2027-04 | Ouvrir |
| NCT07457268 Effect of Transcutaneous Auricular Trigeminal Nerve Stimulation on Migr… |
Transcutaneous Auricular Trigemin… | Migraine | Non applicable | COMPLETED | En attente / non publié | Ordu University | Turkey (Türkiye) · Ordu University, Ordu, Turkey (Tür… | 2026-01-30 → 2026-06-30 | Ouvrir |
| NCT04396236 PIONEER-PEDS1 — A Study of Lasmiditan (LY573144) Treatment in Children … |
Lasmiditan | Migraine | Phase 3 | TERMINATED | En attente / non publié | University of Florence | United States, Belgium, Canada, France, Germany, Indi… | 2020-06-15 → 2025-11-12 | Ouvrir |
| NCT07029126 Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR… |
Fremanezumab | Migraine | À vérifier | COMPLETED | En attente / non publié | Teva Branded Pharmaceutical Produ… | Italy · ASST Spedali Civili Brescia, Brescia, Italy |… | 2024-10-03 → 2026-03-30 | Ouvrir |
| NCT07802912 CBT TIIP — Efficacy of Traditional Integrated Islamic Psychotherapy and… |
CBT TIIP — Efficacy of Traditiona… | Migraine | Non applicable | COMPLETED | En attente / non publié | GIFT University | Pakistan · GIFT University, Gujranwala, Pakistan | 2025-03-10 → 2026-07-20 | Ouvrir |
| NCT05623254 KIMPO — Feasibility and Effectiveness of a Mindfulness Program Delivere… |
KIMPO — Feasibility and Effective… | Migraine | Non applicable | COMPLETED | En attente / non publié | Fondazione I.R.C.C.S. Istituto Ne… | Italy · Fondazione IRCCS Istituto Neurologico C. Best… | 2023-01-02 → 2023-12-31 | Ouvrir |
| NCT06938178 MindMEEG — High-Density EEG-MEG-wearable EEG: Comparison of Quantitativ… |
MindMEEG — High-Density EEG-MEG-w… | Migraine | À vérifier | RECRUITING | En attente / non publié | Fondazione I.R.C.C.S. Istituto Ne… | Italy · Fondazione IRCCS Istituto Neurologico C. Best… | 2024-04-23 → 2026-12-31 | Ouvrir |
| NCT07437313 ADAPT — Marine Lipids Ease Painful TMD |
ADAPT — Marine Lipids Ease Painfu… | Migraine | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University of North Carolina, Cha… | United States · University of North Carolina at Chape… | 2026-09-25 → 2030-02 | Ouvrir |
| NCT07646613 Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihy… |
ASY202 | Migraine | Phase 2 | RECRUITING | En attente / non publié | Aspeya, Inc. | United States · Clinical Neuroscineces Solutions - Or… | 2026-05-19 → 2027-03 | Ouvrir |